The global Quinolone Antibacterial Drug API market projected to hit US$ 2082 million in 2025 to US$ 2790 million in 2031; it is expected to grow at a CAGR of 5.0% from 2025 to 2031.

Global Quinolone Antibacterial Drug API Market Trends and Analysis 2025-31

The global Quinolone Antibacterial Drug API market size is predicted to grow from US$ 2082 million in 2025 to US$ 2790 million in 2031; it is expected to grow at a CAGR of 5.0% from 2025 to 2031. Quinolone antibiotics are a class of broad-spectrum, highly effective antimicrobial agents. They work by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes critical for bacterial DNA replication, ultimately leading to bactericidal effects. These drugs exhibit high activity against Gram-negative bacteria (e.g., Escherichia coli, Pseudomonas aeruginosa) and some Gram-positive bacteria (e.g., Staphylococcus spp.). Common quinolone drugs include ciprofloxacin, levofloxacin, and moxifloxacin, which are widely used to treat respiratory tract infections, urinary tract infections, gastrointestinal infections, and skin and soft tissue infections. United States market for Quinolone Antibacterial Drug API is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Quinolone Antibacterial Drug API is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Quinolone Antibacterial Drug API is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Quinolone Antibacterial Drug API players cover Dr. Reddys Laboratories, Anuh Pharma, Nishchem International, Tocopharm, SGMR Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the Quinolone Antibacterial Drug API Industry Forecast looks at past sales and reviews total world Quinolone Antibacterial Drug API sales in 2024, providing a comprehensive analysis by region and market sector of projected Quinolone Antibacterial Drug API sales for 2025 through 2031. With Quinolone Antibacterial Drug API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Quinolone Antibacterial Drug API industry. This Insight Report provides a comprehensive analysis of the global Quinolone Antibacterial Drug API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Quinolone Antibacterial Drug API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Quinolone Antibacterial Drug API market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Quinolone Antibacterial Drug API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Quinolone Antibacterial Drug API. This report presents a comprehensive overview, market shares, and growth opportunities of Quinolone Antibacterial Drug API market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Ofloxacin &nbsp;&nbsp;&nbsp; Moxifloxacin &nbsp;&nbsp;&nbsp; Ciprofloxacin &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Tablets &nbsp;&nbsp;&nbsp; Injections &nbsp;&nbsp;&nbsp; Eye Drops &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Dr. Reddys Laboratories &nbsp;&nbsp;&nbsp; Anuh Pharma &nbsp;&nbsp;&nbsp; Nishchem International &nbsp;&nbsp;&nbsp; Tocopharm &nbsp;&nbsp;&nbsp; SGMR Pharmaceuticals &nbsp;&nbsp;&nbsp; Sreepathi Pharmaceuticals &nbsp;&nbsp;&nbsp; Neuland Laboratories &nbsp;&nbsp;&nbsp; Guobang Pharma &nbsp;&nbsp;&nbsp; Chongqing Huapont Pharmaceutical &nbsp;&nbsp;&nbsp; Zhejiang Langhua Pharmaceutical &nbsp;&nbsp;&nbsp; Zhejiang East Asia Pharmaceutical &nbsp;&nbsp;&nbsp; Jiangxi Dadi Pharm &nbsp;&nbsp;&nbsp; Zhejiang Jingxin Pharmaceutical &nbsp;&nbsp;&nbsp; Zhejiang Medicine Key Questions Addressed in this Report What is the 10-year outlook for the global Quinolone Antibacterial Drug API market? What factors are driving Quinolone Antibacterial Drug API market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Quinolone Antibacterial Drug API market opportunities vary by end market size? How does Quinolone Antibacterial Drug API break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Quinolone Antibacterial Drug API Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Quinolone Antibacterial Drug API by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Quinolone Antibacterial Drug API by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Quinolone Antibacterial Drug API Segment by Type &nbsp;2.2.1 Ofloxacin &nbsp;2.2.2 Moxifloxacin &nbsp;2.2.3 Ciprofloxacin &nbsp;2.2.4 Others &nbsp;2.3 Quinolone Antibacterial Drug API Sales by Type &nbsp;2.3.1 Global Quinolone Antibacterial Drug API Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Quinolone Antibacterial Drug API Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Quinolone Antibacterial Drug API Sale Price by Type (2020-2025) &nbsp;2.4 Quinolone Antibacterial Drug API Segment by Application &nbsp;2.4.1 Tablets &nbsp;2.4.2 Injections &nbsp;2.4.3 Eye Drops &nbsp;2.4.4 Others &nbsp;2.5 Quinolone Antibacterial Drug API Sales by Application &nbsp;2.5.1 Global Quinolone Antibacterial Drug API Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Quinolone Antibacterial Drug API Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Quinolone Antibacterial Drug API Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Quinolone Antibacterial Drug API Breakdown Data by Company &nbsp;3.1.1 Global Quinolone Antibacterial Drug API Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Quinolone Antibacterial Drug API Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Quinolone Antibacterial Drug API Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Quinolone Antibacterial Drug API Revenue by Company (2020-2025) &nbsp;3.2.2 Global Quinolone Antibacterial Drug API Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Quinolone Antibacterial Drug API Sale Price by Company &nbsp;3.4 Key Manufacturers Quinolone Antibacterial Drug API Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Quinolone Antibacterial Drug API Product Location Distribution &nbsp;3.4.2 Players Quinolone Antibacterial Drug API Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Quinolone Antibacterial Drug API by Geographic Region &nbsp;4.1 World Historic Quinolone Antibacterial Drug API Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Quinolone Antibacterial Drug API Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Quinolone Antibacterial Drug API Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Quinolone Antibacterial Drug API Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Quinolone Antibacterial Drug API Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Quinolone Antibacterial Drug API Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Quinolone Antibacterial Drug API Sales Growth &nbsp;4.4 APAC Quinolone Antibacterial Drug API Sales Growth &nbsp;4.5 Europe Quinolone Antibacterial Drug API Sales Growth &nbsp;4.6 Middle East & Africa Quinolone Antibacterial Drug API Sales Growth 5 Americas &nbsp;5.1 Americas Quinolone Antibacterial Drug API Sales by Country &nbsp;5.1.1 Americas Quinolone Antibacterial Drug API Sales by Country (2020-2025) &nbsp;5.1.2 Americas Quinolone Antibacterial Drug API Revenue by Country (2020-2025) &nbsp;5.2 Americas Quinolone Antibacterial Drug API Sales by Type (2020-2025) &nbsp;5.3 Americas Quinolone Antibacterial Drug API Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Quinolone Antibacterial Drug API Sales by Region &nbsp;6.1.1 APAC Quinolone Antibacterial Drug API Sales by Region (2020-2025) &nbsp;6.1.2 APAC Quinolone Antibacterial Drug API Revenue by Region (2020-2025) &nbsp;6.2 APAC Quinolone Antibacterial Drug API Sales by Type (2020-2025) &nbsp;6.3 APAC Quinolone Antibacterial Drug API Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Quinolone Antibacterial Drug API by Country &nbsp;7.1.1 Europe Quinolone Antibacterial Drug API Sales by Country (2020-2025) &nbsp;7.1.2 Europe Quinolone Antibacterial Drug API Revenue by Country (2020-2025) &nbsp;7.2 Europe Quinolone Antibacterial Drug API Sales by Type (2020-2025) &nbsp;7.3 Europe Quinolone Antibacterial Drug API Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Quinolone Antibacterial Drug API by Country &nbsp;8.1.1 Middle East & Africa Quinolone Antibacterial Drug API Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Quinolone Antibacterial Drug API Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Quinolone Antibacterial Drug API Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Quinolone Antibacterial Drug API Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Quinolone Antibacterial Drug API &nbsp;10.3 Manufacturing Process Analysis of Quinolone Antibacterial Drug API &nbsp;10.4 Industry Chain Structure of Quinolone Antibacterial Drug API 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Quinolone Antibacterial Drug API Distributors &nbsp;11.3 Quinolone Antibacterial Drug API Customer 12 World Forecast Review for Quinolone Antibacterial Drug API by Geographic Region &nbsp;12.1 Global Quinolone Antibacterial Drug API Market Size Forecast by Region &nbsp;12.1.1 Global Quinolone Antibacterial Drug API Forecast by Region (2026-2031) &nbsp;12.1.2 Global Quinolone Antibacterial Drug API Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Quinolone Antibacterial Drug API Forecast by Type (2026-2031) &nbsp;12.7 Global Quinolone Antibacterial Drug API Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Dr. Reddy's Laboratories &nbsp;13.1.1 Dr. Reddy's Laboratories Company Information &nbsp;13.1.2 Dr. Reddy's Laboratories Quinolone Antibacterial Drug API Product Portfolios and Specifications &nbsp;13.1.3 Dr. Reddy's Laboratories Quinolone Antibacterial Drug API Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Dr. Reddy's Laboratories Main Business Overview &nbsp;13.1.5 Dr. Reddy's Laboratories Latest Developments &nbsp;13.2 Anuh Pharma &nbsp;13.2.1 Anuh Pharma Company Information &nbsp;13.2.2 Anuh Pharma Quinolone Antibacterial Drug API Product Portfolios and Specifications &nbsp;13.2.3 Anuh Pharma Quinolone Antibacterial Drug API Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Anuh Pharma Main Business Overview &nbsp;13.2.5 Anuh Pharma Latest Developments &nbsp;13.3 Nishchem International &nbsp;13.3.1 Nishchem International Company Information &nbsp;13.3.2 Nishchem International Quinolone Antibacterial Drug API Product Portfolios and Specifications &nbsp;13.3.3 Nishchem International Quinolone Antibacterial Drug API Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Nishchem International Main Business Overview &nbsp;13.3.5 Nishchem International Latest Developments &nbsp;13.4 Tocopharm &nbsp;13.4.1 Tocopharm Company Information &nbsp;13.4.2 Tocopharm Quinolone Antibacterial Drug API Product Portfolios and Specifications &nbsp;13.4.3 Tocopharm Quinolone Antibacterial Drug API Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Tocopharm Main Business Overview &nbsp;13.4.5 Tocopharm Latest Developments &nbsp;13.5 SGMR Pharmaceuticals &nbsp;13.5.1 SGMR Pharmaceuticals Company Information &nbsp;13.5.2 SGMR Pharmaceuticals Quinolone Antibacterial Drug API Product Portfolios and Specifications &nbsp;13.5.3 SGMR Pharmaceuticals Quinolone Antibacterial Drug API Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 SGMR Pharmaceuticals Main Business Overview &nbsp;13.5.5 SGMR Pharmaceuticals Latest Developments &nbsp;13.6 Sreepathi Pharmaceuticals &nbsp;13.6.1 Sreepathi Pharmaceuticals Company Information &nbsp;13.6.2 Sreepathi Pharmaceuticals Quinolone Antibacterial Drug API Product Portfolios and Specifications &nbsp;13.6.3 Sreepathi Pharmaceuticals Quinolone Antibacterial Drug API Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Sreepathi Pharmaceuticals Main Business Overview &nbsp;13.6.5 Sreepathi Pharmaceuticals Latest Developments &nbsp;13.7 Neuland Laboratories &nbsp;13.7.1 Neuland Laboratories Company Information &nbsp;13.7.2 Neuland Laboratories Quinolone Antibacterial Drug API Product Portfolios and Specifications &nbsp;13.7.3 Neuland Laboratories Quinolone Antibacterial Drug API Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Neuland Laboratories Main Business Overview &nbsp;13.7.5 Neuland Laboratories Latest Developments &nbsp;13.8 Guobang Pharma &nbsp;13.8.1 Guobang Pharma Company Information &nbsp;13.8.2 Guobang Pharma Quinolone Antibacterial Drug API Product Portfolios and Specifications &nbsp;13.8.3 Guobang Pharma Quinolone Antibacterial Drug API Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Guobang Pharma Main Business Overview &nbsp;13.8.5 Guobang Pharma Latest Developments &nbsp;13.9 Chongqing Huapont Pharmaceutical &nbsp;13.9.1 Chongqing Huapont Pharmaceutical Company Information &nbsp;13.9.2 Chongqing Huapont Pharmaceutical Quinolone Antibacterial Drug API Product Portfolios and Specifications &nbsp;13.9.3 Chongqing Huapont Pharmaceutical Quinolone Antibacterial Drug API Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Chongqing Huapont Pharmaceutical Main Business Overview &nbsp;13.9.5 Chongqing Huapont Pharmaceutical Latest Developments &nbsp;13.10 Zhejiang Langhua Pharmaceutical &nbsp;13.10.1 Zhejiang Langhua Pharmaceutical Company Information &nbsp;13.10.2 Zhejiang Langhua Pharmaceutical Quinolone Antibacterial Drug API Product Portfolios and Specifications &nbsp;13.10.3 Zhejiang Langhua Pharmaceutical Quinolone Antibacterial Drug API Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Zhejiang Langhua Pharmaceutical Main Business Overview &nbsp;13.10.5 Zhejiang Langhua Pharmaceutical Latest Developments &nbsp;13.11 Zhejiang East Asia Pharmaceutical &nbsp;13.11.1 Zhejiang East Asia Pharmaceutical Company Information &nbsp;13.11.2 Zhejiang East Asia Pharmaceutical Quinolone Antibacterial Drug API Product Portfolios and Specifications &nbsp;13.11.3 Zhejiang East Asia Pharmaceutical Quinolone Antibacterial Drug API Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Zhejiang East Asia Pharmaceutical Main Business Overview &nbsp;13.11.5 Zhejiang East Asia Pharmaceutical Latest Developments &nbsp;13.12 Jiangxi Dadi Pharm &nbsp;13.12.1 Jiangxi Dadi Pharm Company Information &nbsp;13.12.2 Jiangxi Dadi Pharm Quinolone Antibacterial Drug API Product Portfolios and Specifications &nbsp;13.12.3 Jiangxi Dadi Pharm Quinolone Antibacterial Drug API Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Jiangxi Dadi Pharm Main Business Overview &nbsp;13.12.5 Jiangxi Dadi Pharm Latest Developments &nbsp;13.13 Zhejiang Jingxin Pharmaceutical &nbsp;13.13.1 Zhejiang Jingxin Pharmaceutical Company Information &nbsp;13.13.2 Zhejiang Jingxin Pharmaceutical Quinolone Antibacterial Drug API Product Portfolios and Specifications &nbsp;13.13.3 Zhejiang Jingxin Pharmaceutical Quinolone Antibacterial Drug API Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.13.4 Zhejiang Jingxin Pharmaceutical Main Business Overview &nbsp;13.13.5 Zhejiang Jingxin Pharmaceutical Latest Developments &nbsp;13.14 Zhejiang Medicine &nbsp;13.14.1 Zhejiang Medicine Company Information &nbsp;13.14.2 Zhejiang Medicine Quinolone Antibacterial Drug API Product Portfolios and Specifications &nbsp;13.14.3 Zhejiang Medicine Quinolone Antibacterial Drug API Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.14.4 Zhejiang Medicine Main Business Overview &nbsp;13.14.5 Zhejiang Medicine Latest Developments 14 Research Findings and Conclusion

Report	Global Quinolone Antibacterial Drug API Market Growth 2025-2031
Selected License	Multi ID: LPI17495

Buyer Information

Order Summary